Does ENZALUTAMIDE Cause Decreased appetite? 3,069 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,069 reports of Decreased appetite have been filed in association with ENZALUTAMIDE (Xtandi). This represents 6.2% of all adverse event reports for ENZALUTAMIDE.
3,069
Reports of Decreased appetite with ENZALUTAMIDE
6.2%
of all ENZALUTAMIDE reports
413
Deaths
811
Hospitalizations
How Dangerous Is Decreased appetite From ENZALUTAMIDE?
Of the 3,069 reports, 413 (13.5%) resulted in death, 811 (26.4%) required hospitalization, and 21 (0.7%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Nausea (2,898)
Dizziness (2,776)
Diarrhoea (2,470)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ENZALUTAMIDE Alternatives Have Lower Decreased appetite Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE